MAbHuman: antibody framework modification by CDR grafting

MAbHuman: antibody framework modification by CDR grafting

CMC & developability

Information

MAbHuman; identification of human frameworks for CDR grafting (58 million human sequences in our database) Deliverable: 5 antibody sequences in 10 days

MAbSilicoMAbSilico provides a formal embedded Artificial Intelligence technology for antibody discovery, reducing the risks of failure and the duration of discovery and preclinical steps, as well as strengthening intellectual property protection. Conventional approaches for the drug discovery take up to three years, while MAbSilico technologies allow shrinking this time to a few weeks. With lead selection, characterization and optimization, MAbSilico gives you AI-based solutions using antibody sequences and delivering qualified data within 10 days.

Log in

See all the content and easy-to-use features by logging in or registering!